Application Note: The Dual Screen: Parallel genome-wide CRISPRi & CRISPRa screening
22 August 2022
In this application note, Horizon Discovery describes its Dual Screen, which uses CRISPRi and CRISPRa gene modulation technologies in parallel and provides the ability to identify drug-gene interactions through paired gene perturbation analysis. This approach promises to offer researchers a novel, powerful, and systematic way to explore drug mechanisms of
action.